ICDs Constitute More Than 60% Of The Global Cardiac Rhythm Management Market And...

ICDs Constitute More Than 60% Of The Global Cardiac Rhythm Management Market And Served As The Major Growth Driver For The MarketDUBLIN, Ireland--(Business Wire)--Research and Markets

(http://www.researchandmarkets.com/reports/c75806) has announced theaddition of "Global Cardiac Rhythm Management Market: ICDs andEmerging Markets to Drive Growth" to their offering. Market demand, innovative products, government regulations andreimbursement policies are the four factors that have been changingthe global healthcare industry continuously. These factors have alsoinfluenced the market for specialized medical devices - Cardiac RhythmManagement (CRM), which mainly comprises Implantable Cardiac RhythmDevices (ICD) and Pacemakers. ICDs constitute more than 60% of the global CRM market and servedas the major growth driver for CRM market. However, in 2006, themarket registered a negligible growth following product recalls byleading companies like Medtronic and Guidant/Boston Scientific.Nevertheless the ICDs segment is expected to grow at a satisfactoryrate 2008 onwards and specifically in Europe and other emergingcountries. The recall of ICDs by world's top medical device manufacturers -Medtronic and Guidant/Boston Scientific in 2005 became the majorreason behind the market slow down during 2006. On the other hand, the market for pacemakers is heading towardssaturation especially in the USA and Europe because of the highpenetration rates by population in these regions. Still, in Japan andin other Asian countries like China and India, it holds tremendouspotential. The current report analyzes the CRM market with specific focus onICDs. In the present study, the growth of ICDs and pacemakers in thelast four years has been assessed and the future potential of thesemarkets has been studied. As only three companies - Medtronic, St.Jude and Boston Scientific is defining this market space, thesecompanies have been profiled and their strategies mapped. Further, thereport also presents an assessment of the future of the CRM market. 1. Cardiovascular Diseases: Incidence and Treatment 2. Cardiac Rhythm Management Market 3. Implantable Cardiac Rhythm Devices (ICD) Market 4. Pacemaker Market 5. Growth of ICD Market by Geography 6. Competitive Landscape 7. Leading Players 7.1 Medtronic 7.2 Boston Scientific 7.3 St. Jude Medical 8. Outlook Companies mentioned: Medtronic Boston Scientific Jude Medical For more information visithttp://www.researchandmarkets.com/reports/c75806Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFax: +353-1-4100-980Copyright Business Wire 2007